Noah Goodman, Chief Business Officer: Kymera Therapeutics KYMR Sell · Filed 04/10

Trade details

Type: Insider sale
Amount: $268,002.28
Shares · price: 3,094 sh · $86.62 a share
Held after: 58,712.44 sh
Stock: Kymera Therapeutics KYMR
Person: Noah GoodmanChief Business Officer
Trade date: 26/04/09
Filed: 26/04/10
Days to filing: 1 days

Sold 5.0% of holdings

Share of holding sold: 5.0%

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 03/10~05/09

Noah Goodman's recent trades

Noah GoodmanChief Business Officer
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$388.6K
3,389 sh
$388.6K
Filed 07/01
Traded 07/01
Noah GoodmanChief Business Officer
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$297.5K
2,500 sh
$297.5K
Filed 06/25
Traded 06/25
Noah GoodmanChief Business Officer
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$272.5K
2,500 sh
$272.5K
Filed 06/25
Traded 06/25
Noah GoodmanChief Business Officer
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$499.4K
5,000 sh
$499.4K
Filed 06/25
Traded 06/25
Noah GoodmanChief Business Officer
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$247.5K
2,500 sh
$247.5K
Filed 06/22
Traded 06/22

Noah Goodman, Chief Officer — sold $268K of Kymera Therapeutics KYMR · 5.0% of holdings · 10b5-1 plan | Whalegun